HIMS & HERS HEALTH INC (HIMS) Stock Earnings & Estimates
NYSE:HIMS - US4330001060 - Common Stock
44.01 USD
-1.34 (-2.95%)
44.17 USD
+0.16 (+0.36%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 526.916M 93.81% | 872M 65.49% | 1.477B 69.33% | 2.389B 61.80% | 2.852B 19.38% | 3.37B 18.16% | 3.571B 5.96% | 3.897B 9.13% | 6.174B 58.43% | 7.312B 18.43% | 8.652B 18.33% | |
| EBITDA YoY % growth | -58.904M 39.67% | -16.493M 72.00% | 85.092M 615.93% | 328.81M 286.42% | 425.29M 29.34% | 546.54M 28.51% | 623.63M 14.11% | 764.49M 22.59% | 1.339B 75.15% | 1.6B 19.49% | 1.902B 18.88% | |
| EBIT YoY % growth | -66.378M 34.74% | -26.008M 60.82% | 68.004M 361.47% | 176.59M 159.68% | 268.29M 51.93% | 351.48M 31.01% | 404.23M 15.01% | 534.68M 32.27% | 450.84M -15.68% | 561M 24.43% | N/A | |
| Operating Margin | -12.60% | -2.98% | 4.61% | 7.39% | 9.41% | 10.43% | 11.32% | 13.72% | 7.30% | 7.67% | N/A | |
| EPS YoY % growth | -0.32 42.75% | -0.11 65.63% | 0.54 590.91% | 0.60 11.07% | 0.82 36.83% | 1.04 26.31% | 2.41 132.23% | 3.09 28.39% | 3.97 28.38% | 5.10 28.53% | 6.55 28.40% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.11 -65.81% | 0.13 18.86% | 0.24 19.85% | 0.28 63.50% | 0.24 121.40% | 0.27 106.74% | 0.32 31.91% | 0.44 57.80% | 0.19 -20.00% | 0.26 -5.66% |
| Revenue Q2Q % growth | 592.19M 47.47% | 643.12M 33.67% | 672.35M 14.73% | 683.87M 25.52% | 709.92M 19.88% | 769.05M 19.58% | 771.07M 14.68% | 761.82M 11.40% | 784.66M 10.53% | 854.56M 11.12% |
| EBITDA Q2Q % growth | 69.286M 102.24% | 79.594M 99.75% | 98.153M 48.27% | 107.46M 107.87% | 103.76M 49.76% | 115.66M 45.31% | 132.9M 35.40% | 143.61M 33.64% | 128.61M 23.95% | 143.02M 23.66% |
| EBIT Q2Q % growth | 25.805M 11.08% | 34.845M 53.10% | 57.554M -0.63% | 70.658M 114.41% | 62.933M 143.88% | 74.902M 114.96% | 61.2M 6.33% | 86.496M 22.42% | 35.292M -43.92% | 47.838M -36.13% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.17 183.33% | 0.15 | 0.02 | 10.29% |
| Q1 2025 Q2Q % growth | 0.20 300.00% | 0.12 | 0.08 | 62.17% |
| Q4 2024 Q2Q % growth | 0.11 1,000.00% | 0.11 | 0.00 | 4.62% |
| Q3 2024 Q2Q % growth | 0.32 900.00% | 0.04 | 0.28 | 666.87% |
| Q2 2024 Q2Q % growth | 0.06 300.00% | 0.04 | 0.02 | 37.66% |
| Q1 2024 Q2Q % growth | 0.05 200.00% | 0.01 | 0.04 | 308.50% |
| Q4 2023 Q2Q % growth | 0.01 120.00% | -0.02 | 0.03 | 152.29% |
| Q3 2023 Q2Q % growth | -0.04 55.56% | -0.03 | -0.01 | -24.77% |
| Q2 2023 Q2Q % growth | -0.03 70.00% | -0.06 | 0.03 | 45.82% |
| Q1 2023 Q2Q % growth | -0.05 37.50% | -0.07 | 0.02 | 31.37% |
| Q4 2022 Q2Q % growth | -0.05 66.67% | -0.07 | 0.02 | 26.47% |
| Q3 2022 Q2Q % growth | -0.09 -13.92% | -0.10 | 0.01 | 13.49% |
| Q2 2022 Q2Q % growth | -0.10 -233.33% | -0.10 | 0.00 | 3.57% |
| Q1 2022 Q2Q % growth | -0.08 73.33% | -0.07 | -0.01 | -10.08% |
| Q4 2021 Q2Q % growth | -0.15 -114.29% | -0.07 | -0.08 | -102.84% |
| Q3 2021 Q2Q % growth | -0.08 | -0.06 | -0.02 | -25.59% |
| Q2 2021 Q2Q % growth | -0.03 | -0.08 | 0.05 | 64.24% |
| Q1 2021 Q2Q % growth | -0.30 | -0.11 | -0.19 | -180.78% |
| Q4 2020 Q2Q % growth | -0.07 | -0.16 | 0.09 | 57.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 544.833M 72.61% | 562.65M | -17.817M | -3.17% |
| Q1 2025 Q2Q % growth | 586.01M 110.67% | 548.97M | 37.04M | 6.75% |
| Q4 2024 Q2Q % growth | 481.139M 95.45% | 479.72M | 1.419M | 0.30% |
| Q3 2024 Q2Q % growth | 401.556M 77.13% | 389.85M | 11.706M | 3.00% |
| Q2 2024 Q2Q % growth | 315.648M 51.82% | 305.94M | 9.708M | 3.17% |
| Q1 2024 Q2Q % growth | 278.171M 45.81% | 275.79M | 2.381M | 0.86% |
| Q4 2023 Q2Q % growth | 246.169M 47.23% | 251.38M | -5.211M | -2.07% |
| Q3 2023 Q2Q % growth | 226.699M 56.52% | 224.45M | 2.249M | 1.00% |
| Q2 2023 Q2Q % growth | 207.912M 83.08% | 209.06M | -1.148M | -0.55% |
| Q1 2023 Q2Q % growth | 190.77M 88.30% | 182.66M | 8.11M | 4.44% |
| Q4 2022 Q2Q % growth | 167.203M 97.41% | 164.39M | 2.813M | 1.71% |
| Q3 2022 Q2Q % growth | 144.836M 95.27% | 132.95M | 11.886M | 8.94% |
| Q2 2022 Q2Q % growth | 113.563M 87.11% | 105.96M | 7.603M | 7.18% |
| Q1 2022 Q2Q % growth | 101.314M 93.67% | 92.998M | 8.316M | 8.94% |
| Q4 2021 Q2Q % growth | 84.699M | 78.329M | 6.37M | 8.13% |
| Q3 2021 Q2Q % growth | 74.173M | 71.942M | 2.231M | 3.10% |
| Q2 2021 Q2Q % growth | 60.692M | 57.623M | 3.069M | 5.33% |
| Q1 2021 Q2Q % growth | 52.314M | 49.79M | 2.524M | 5.07% |
| Q4 2020 Q2Q % growth | 37.744M | -37.744M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -33.42% | -40.41% | -11.98% | -5.16% |
| Revenue | -0.71% | 1.3% | -0.29% | -0.25% |